Drug firm GSK fined $2.6 million for collusion

South Korea's anti-trust agency has fined drugmaker GlaxoSmithKline three billion won ($2.6 million) for conspiring with a Seoul rival over the sale of drugs, an official said Monday.

The (FTC) said GSK in 2000 offered Dong-A Pharmaceutical the exclusive right to sell its anti-nausea drug Zofran and an anti-viral medication called Valtrex.

In return, the FTC said the British-based multinational demanded that Dong-A stop selling a cheaper of Zofran which the Seoul firm had introduced in 1998.

GSK also asked that Dong-A never produce or sell any drugs that could compete against Zofran and Valtrex, Kim Jun-Ha, a FTC official involved in the case, told AFP.

"With the cheaper generics made by Dong-A taken off the market, the on patients and on the government's health insurance budget has increased," Kim said.

The FTC said in a statement it estimated GSK had made wrongful gains of about 16 billion won. It said "the two firms shared benefits that were to go to consumers".

Dong-A was fined 2.1 billion won for the collusion, the agency added.

GSK's South Korean unit called the decision "very regrettable" and "inappropriate" and said it would appeal in court.

"We simply exercised our legitimate patent rights," it said in a statement, adding that there was no illegality.

add to favorites email to friend print save as pdf

Related Stories

Generics controversy issue widens

Jun 05, 2006

A dispute between the U.S. Justice Department and Federal Trade Commission over generic drugs is reportedly widening with implications for the drug firms.

Recommended for you

Most US babies get their vaccines, CDC says

21 hours ago

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

Expression of privilege in vaccine refusal

Aug 27, 2014

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

User comments